Can Early ART Help to Protect HIV-Positive Children Against Vaccine-Preventable Illnesses?
Among children with vertically transmitted HIV infection, those who initiated antiretroviral therapy by age 1 had better B-cell function and greater evidence of protection from childhood vaccines than did children who started ART later.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)